Germany's Merck to make new bid to enter U.S. MS pill market
December 14, 2017 at 12:55 PM EST
FRANKFURT, Dec 14 (Reuters) - Germany's Merck KGaA is reviving plans to bring an oral multiple sclerosis (MS) treatment to the U.S. market, hoping for blockbuster sales, after regulators' concerns about side effects scuttled its ambitions almost seven years ago.
